Today's top medical abstracts
Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Rheumatology
For Practicing
Rheumatologists
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Rheumatologists
Today's Rheumatology News: VGX-1027 To Undergo Additional Testing For RA
D Scott Cunningham MD, PhD, MDLinx Rheumatology
Today's Rheumatology News: FDA Approves Actemra
D Scott Cunningham MD, PhD, MDLinx Rheumatology
From the Editors: New Clinical-Only Option for MDLinx!
Stephen Smith, MDLinx
  See all
systemic sclerosis;Anti-BNA polymerase antibodies Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Anti-RNA polymerase III antibodies in patients with systemic sclerosis detected by indirect immunofluorescence and ELISA
Rheumatology, 06/19/08
Print     Email This Article     Save in My Library   Free Abstract
Parker JC et al. – In a large population of SSc patients anti-RNA polymerase III antibody (ARA) ELISA was demonstrated to have a high analytical sensitivity and specificity with minimal overlap between ARA and other SSc-specific autoantibodies. Additionally, it is demonstrated that the presence of ARA correlates with identifiable patterns by indirect immunofluorescence (IIF) on HEp-2 cell substrate.

Methods
  • A study to evaluate the analytical performance of an ELISA for the detection of ARA and to assess IIF as a method for identifying this Ab
  • Presence of ARA in sera from 1018 SSc pts was tested by ELISA
  • The sera divided into sub-populations: presence of specific autoantibodies; ANA pattern or the absence of both
  • Pts with ARA (n=209) had been identified by characteristic ANA pattern by IIF on HEp-2 cell substrate
  • The remaining 809 SSc pts acted as a control group

Results
  • 150/157 pts were positive by ELISA providing a sensitivity of 96%
  • In the group where ARA had only been assessed by IIF, 100% were ELISA positive
  • The ANA patterns were a fine-speckled nucleoplasmic stain with additional occasional bright dots, with or w/o concurrent punctate nucleolar staining
  • In the SSc control group, the ELISA attained a specificity of 98%, ARA being detected in 17/809 pts

Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.